Clinical Trial Update: Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for treatment of relapsed or refractory natural killer/T-cell lymphoma, nasal type.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Killer T-cell Lymphoma Nasal Type

Snippet

Sponsor: Mingzhi Zhang | Conditions: Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Phase 2 | Status: UNKNOWN